Human alveolar macrophages (AM) were obtained from eight normal volunteers using fiberoptic bronchoscopic lavage to explore potential interrelationships among leukocytes in pulmonary defense against infection. AM placed in monolayer tissue cultures released material into culture supernatants with the capacity to enhance the bactericidal capacity of human neutrophils. Neutrophils preexposed to supernatants killed Pseudomonas aeruginosa from 70 to 90% more efficiently than control cells (P < 0.02). AM culture supernatants contained this material by 4 h of incubation, and in vitro stimulation of AM cultures with heat-killed P. aeruginosa further increased its production.
Introduction
The human alveolar macrophage (AM)' is a potent secretory cell. In recent years, it has become evident that certain of these secretory activities may be critical to intrapulmonary defenses against infection (1) (2) (3) (4) . We have recently observed that supernatants obtained from short-term cultures of normal Received for publication 28 November 1983 and in revised form 14 December 1984.
1. Abbreviations used in this paper: AM, alveolar macrophages; cfu, colony-forming units; f-met-leu-phe, formyl-methionyl-leucyl-phenylalanine; GBSS, Gey's balanced salt solution; HIFBS, heat-inactivated fetal bovine serum; IL-l, interleukin-l; LTB4, leukotriene B4; NAF, neutrophil-activating factor; NANA, N-acetylneuraminic acid; PMA, phorbol myristate acetate; SOD, superoxide dismutase. human AM contain material that, upon ekposure to neutrophils, enhances bactericidal activity of neutrophils (5) . Neutrophils incubated with these supernatants demonstrated an increased respiratory burst during subsequent phagocytic challenge, an effect that was not related to increased phagocytic rates among the supernatant-exposed neutrophils. The addition of cycloheximide to AM tissue cultures eliminated most of the neutrophil-activating material in culture supernatants, suggesting that this material was synthesized and secreted by macrophages. It was not clear from these initial observations, however, whether AM culture supernatants contained one or several active principles. Nor was it clear whether these studies had detected a previously unknown substance, or whether they were simply describing new functional properties for previously identified AM secretory products (2) (3) (4) 6 ). The present study was undertaken to address these issues.
Methods
Bronchoalveolar lavage. Fiberoptic bronchoscopy was performed on eight healthy human volunteers (six male, two female) after informed consent was obtained. Volunteers were 25-36 yr of age, and half were smokers. The nose and upper airways were anesthetized with 4% lidocaine and a bronchoscope (model BF B2; Olympus Corporation of America, New Hyde Park, NY) was passed transnasally. The bronchoscope was wedged in a subsegmental bronchus of the right middle lobe or lingula and 200-250 ml of sterile isotonic saline was instilled in 50-ml aliquots and aspirated by suction apparatus (1) .
Preparation ofAM tissue cultures and culture supernatants. Bronchoalveolar lavage fluid specimens were filtered through coarse gauze to remove mucus, then centrifuged at 500 g for 9 min at 40C to sediment cells. Supernatants were removed and cells resuspended and washed by gentle agitation in modified Hanks' balanced salt solution (HBSS) (Ca++-and Mge-free; Grand Island Biological Co., Grand Island, NY). Cells were counted by hemocytometer, and differential counts were made using Wright-Giemsa stained smears. In addition, wet mounts were prepared with dilute neutral red stain to differentiate macrophages from lymphocytes (7) . Cell (2 X 106/ml) were placed into 13 X 100 mm-round-bottom plastic tubes (Falcon Labware) and incubated in suspension using a tilting rack. In addition, selected AM cultures were exposed to heat-killed Pseudomonas aeruginosa (see below) at 1 X 107 colony-forming units (cfu)/ml concentration, or latex particles (1.099 Am) (Dow Chemical U.S.A., Health & Consumer Products Div., Indianapolis, IN) suspended at 2% concentration, during 4-or 24-h incubations. After incubation, AM culture supernatants and fluids from cell-free plates were removed by Pasteur pipette, centrifuged at 500 g for 8 min to remove cellular debris, passed through micropore filters (0.45 Mm), and frozen to -700C.
Preparation and preincubation of neutrophils. Venous blood from healthy volunteers was collected into syringes containing heparin and sedimented with dextran (Macrodex 6%; Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, NJ); neutrophils were then collected by processing the leukocyte-rich fractions over density cushions (FicollPaque; Pharmacia Fine Chemicals) (8) , and residual erythrocytes were lysed with 0.2% saline exposures. Tonicity was rapidly restored using 1.6% saline. Resultant cell preparations contained 99% polymorphonuclear leukocytes with -95% viability (trypan blue dye exclusion). Wright-Giemsa stains revealed that >95% of these cells were neutrophils. Neutrophils were suspended to a concentration of 1 X 107 cells/ml in either M199 from the cell-free plates plus 10% HIFBS, native AM culture supernatants plus 10% HIFBS, or partially purified AM supernatants (by gel filtration and chromatofocusing, see below). Each of these mixtures was incubated for 15 min at 370C in a shaking water bath, after which neutrophils were sedimented at 500 g, supernatants removed, and cells resuspended to 1 X 107 neutrophils/ml in HBSS with Ca++ and Mg". Cell viabilities of these final suspensions were routinely 98-99% (trypan blue dye).
Bactericidal assay. A serum-resistant strain of P. aeruginosa (Pseudomonas, strain 220) was prepared as described previously (9) , and suspended in isotonic saline to a final concentration of 1 X 108 cfu/ ml. Mixtures (0.3 ml vol) containing 1 X 107 bacteria, 1 X 106 preincubated neutrophils (see above), and 7% fresh autologous human serum were prepared in triplicate in plastic tubes (12 X 75 mm; Falcon Labware) and incubated at 37°C in a shaking water bath. After 0 and 120 min, samples were serially diluted in distilled H20 and cultured using the pour-plate technique.
Positive-pressure ultrafiltration and gel filtration of AM culture supernatants. AM supernatant specimens were fractionated using a positive-pressure ultrafiltration apparatus (Amicon Corp., Scientific Sys. Div., Danvers, MA). For fractionation, 2-ml samples were diluted with M199 to 10 ml, then filtered using a filter (model UM-10; Amicon Corp.) and concentrated to original volumes. Filtrates were collected and also concentrated to original volumes using another filter (model UM-05; Amicon Corp.). Resulting fractions, containing material of > 10,000 D (model UM-0), or between 500 and 10,000 D (model UM-05), were then assayed for neutrophil-activating capacity.
1 -ml samples of supernatant fluids from selected AM cultures were gel-filtered using 1.0 X 60-cm columns containing Sephadex G-50 (Pharmacia Fine Chemicals). The columns were operated at 4°C using sterile phosphate-buffered saline (PBS), pH 7.4, and 1. Enzyme digestion. Insoluble trypsin, chymotrypsin, and neuraminidase were obtained from Sigma Chemical Co. Enzyme digestion experiments were performed on neutrophil-activating factor (NAF) that had been partially purified by gel filtration, followed by chromatofocusing, and finally dialyzed against HBSS (as above). Enzyme concentrations used for digestions were 3.2% (6.4 U/ml) trypsin, 1.6% (7.2 U/ml) chymotrypsin, and 1.6% (0.64 U/ml) neuraminidase. For experiments, enzymes were suspended in 1.0-ml aliquots of NAF and mixtures were incubated on a tilter at 370C for 45 or 180 min. After incubations, insoluble enzyme was separated from NAF by centrifugation (3,000 g), and supernatants were then assayed for neutrophilactivating capacity. Control experiments included HBSS incubated with each of the enzymes, and NAF and HBSS preincubated for 180 min without enzymes.
To document that the neuraminidase used for these digestions was active at physiologic pH, we carried out enzyme digestions of N-acetyl neuraminlactose (from bovine colostrum; Sigma Chemical Co.) at pH 5.5 and at physiologic pH (7.35), both in HBSS. Reaction mixtures were incubated for 30 min at 370C, and micromoles of N-acetylneuraminic acid (NANA) in the samples was assayed by the thiobarbituric acid method of Warren (10) . Synthetic NANA (Aldrich Chemical Co., Inc., Milwaukee, WI) was used to establish the standard curve. In comparing the micromoles of NANA released per milliliter at each pH, there was a 38% reduction in activity at the higher pH, indicating that our enzyme as used in this study did retain considerable activity. Neuraminidase used for assays was lot 33F-9560 (Sigma Chemical Co.) and contained minimal protease activity (0.007 U protease/l U neuraminidase).
Chemotactic assay. Chemotactic assays were carried out on alternate eluant fractions from the gel filtration preparations using modified Boyden chambers (Ahlco Manufacturing Co., Inc., Southington, CT). For these assays, human neutrophils were collected and prepared as described above, except that final suspensions were made in Gey's balanced salt solution (GBSS) plus 0.4% bovine serum albumin (BSA; Sigma Chemical Co.), at a concentration of 2.5 x 106 cells/ml. For assays, 400 Ml of neutrophil suspension was placed in the upper compartments of the chambers, and the eluant fraction (or control substances) loaded into the lower compartment. Negative controls included GBSS plus 0.4% BSA, and also PBS with and without 0.4% BSA. No significant differences in chemotactic activity were detected among the three negative control suspensions used. For positive controls, a 10-8-M suspension of formyl-methionyl-leucyl-phenylalanine (f-met-leu-phe) was used (11). Upper and lower compartments were separated by 3-agm pore cellulose nitrate filters (Membranfilter, Sartorius, Gottingen, Federal Republic of Germany), and chambers were incubated for 30 min at 37°C in a moist atmosphere of 5% CO2. Filters were then removed, fixed in methanol, and prepared for microscopy, as previously described (11). Triplicate filters were obtained for each specimen (or control). The distance in micrometers the leading pair of neutrophils had migrated into each filter was determined using a microscope micrometer (12) , and readings were repeated five times per filter. Chemotaxis for each specimen was expressed as the mean distance (Mm) of migration for all readings.
Leukotriene B4 (LTBJ assay. AM from four different volunteers were prepared in culture exactly as described above. Supernatants were then harvested after 24-h incubations, 1.5 vol of absolute methanol was added, and the samples stored at -70°C, under argon, until used for measurement of LTB4. Before the LTB4 assay, the specimens were evaporated to dryness under vacuum. The residues were resuspended in 500 gl of 10 mM Tris-HCl buffer, pH 7.4, containing 0.15 M NaCl and 0.1% gelatin, and a 100-Ml sample of each was assayed in a radioimmunoassay for LTB4 (13, 14) . The standard curve for the inhibition of binding of 3H-LTB4 to anti-LTB4 antibody was obtained over the ranges of 0.01-10 ng LTB4; the ID5o for LTB4 was 0.18 ng (15) . The LTB4 used was made by total chemical synthesis (16) (kindly given by Professor E. J. Corey, Harvard University, Cambridge, MA). The purity of the compound was confirmed by its elution as a homogeneous peak after reverse phase high pressure liquid chromatography, and its concentration was determined from the maximum UV absorbance using the maximal molar extinction coefficient of 51,000 cm-'M-'. To assess the recovery of immunoreactive LTB4 from AM supernatants, defined quantities of LTB4 as determined by UV absorbance were added to AM supernatants. The supernatants were processed as described above and recoveries of immunoreactive LTB4 were consistently >90% for 0.03-10 ng LTB4.
Superoxide anion (O2) assay. The production of°2 by neutrophils preincubated with partially purified (gel filtration) NAF was measured by the capacity of O2 to reduce ferricytochrome c to ferrocytochrome c (17). Control neutrophil preparations were preincubated with PBS only. After preincubation for 15 min, neutrophils were washed and resuspended (5 X 106 cells in HBSS with Ca++ and Mg++) with ferricytochrome c, type VI (1.24 mg/ml) (Sigma Chemical Co.), either with or without superoxide dismutase (SOD, 100 Ag/ml; Sigma Chemical Co.). These reagents were prepared immediately before usage. Phorbol myristate acetate (PMA; Sigma Chemical Co.) or viable P. aeruginosa were used to trigger the respiratory burst. All preparations were made in triplicate. Neutrophil reaction-mixtures were incubated for 45 min at 37°C in a shaking water bath, after which cells were sedimented at 300 g, and supernatants removed for assay. Identically prepared reactionmixtures were also assayed without incubation, to determine background activity. Supernatants were diluted 1:4 in HBSS with Ca++ and Mge' and assayed for reduction of ferricytochrome c by spectrophotometric analysis (Cary 219, recording spectrophotometer; Cary Instruments, Monrovia, CA). Nanomoles of cytochrome c reduced were calculated from the maximal increase in absorbance measured using an absorption coefficient of 21.1 mM-'cm-' (18). Superoxide-dependent cytochrome c reduced was calculated by subtraction of the value for cytochrome c reduced measured in the reaction-mixtures containing SOD from the value measured in the reaction-mixtures without SOD. Results are expressed as nanomoles of cytochrome c reduced per 5 X 106 neutrophils.
Immunological methods and chemical reagents. Polyclonal goat antisera to human C5 was obtained from Atlantic Antibodies (Scarborough, ME). Goat anti-human C3 was kindly donated by Dr. Harvey R. Colten, Children's Hospital Medical Center, Boston, MA (19) . Rabbit anti-human albumin was obtained from Cappel Laboratories, Cochranville, PA. Agar-gel double diffusion assays were carried out by the method of Ouchterlony (20) . The functional neutralizing capacity of the anti-C5 antisera used was verified by the demonstration that anti-C5 antisera could eliminate neutrophil chemotactic activity in zymosan-activated fresh human serum (distances migrated [Lm] : 114±8, activated serum; 52±7, activated serum reacted 2 h with antisera; 46±8, GBSS control). 1-ml aliquots of AM culture supernatant specimens were then reacted with 0.1 ml antisera to C3, C5, or albumin for these experiments to determine whether antisera-induced neutralization was complement specific. Ml199 alone was concomitantly incubated with these antisera. Untreated AM supernatant and M199 were also incubated for 2 h at room temperature. All reaction mixtures, plus the untreated materials, were then used for the conventional 15-min preexposure of neutrophils, followed by bactericidal assay.
N-f-met-leu-phe was obtained in powdered form from Bachem Fine Chemicals (Torrance, CA), dissolved in dimethyl sulfoxide, and diluted to working concentrations in GBSS. The final concentration of dimethyl sulfoxide was <1%. Zymosan was obtained from Difco Laboratories Inc. (Detroit, MI), and was used to activate fresh human serum, as previously described (2) .
Statistical analysis. Experimental data were analyzed using the paired two-tailed t test. A P value of <0.05 was considered significant.
Results
Initial studies using the eight newly generated human AM culture specimens confirmed our previous observation (5) . Neutrophils preexposed to supernatants from 24-h AM cultures reduced numbers of viable Pseudomonas by 3.01±0.33 (log1o) during 120-min incubations, while a mean decrease (log1o) of 2.13±0.27 was noted for neutrophils preexposed to medium only (P < 0.02). There was no significant difference between the AM supernatants obtained from smokers and nonsmokers in their capacity to activate neutrophils. In additional experiments, serial twofold dilutions of AM culture (24 h) supernatants were made in M199 before neutrophil exposure. Considerable neutrophil-activating capacity remained in preparations up to dilutions of 1:8 (P < 0.05) (Fig. 1) .
Influence of AM cell culture conditions on secretion of neutrophil-activating material. The optimal incubation time for recovery of neutrophil-activating material was 4 h, and incubation of AM for longer periods did not increase the amount of detectable neutrophil-activating material (Fig. 2) . The maximal recovery of AM-derived material was achieved when the cell cultures were exposed to 107 cfu heat-killed P. aeruginosa (Fig. 2) . Challenge of monolayers with inert latex particles did not enhance recovery of AM-derived material, however. Finally, it was apparent that surface contact of AM was a requirement for stimulation of AM-derived material, since AM incubated in suspension failed to produce this substance (Fig. 2) .
Exclusion ofcomplement components and LTB4 to account for neutrophil-activating material in AM culture supernatants.
Experiments were carried out to explore the possible association of neutrophil-activating material in AM supernatants with LTB4, an arachidonic acid metabolite known to be produced by human AM (6, 14, 21) , and also known to stimulate neutrophils (22). Previous experience has indicated that calcium ionophore stimulation of AM is necessary for optimal LTB4 production (6). However, it was our intent to duplicate the cell culture conditions used herein for producing NAF. Thus, all sets of AM cultures (2 X 106 cells/ml) were incubated for 24 h without calcium ionophore stimulation. The concentra- 24) , experiments were carried out to explore the possible association of neutrophilactivating material in AM supernatants with C3 or C5. Antisera to C3, C5, and albumin were reacted against fresh human sera, and also against five separate AM supernatant specimens in agar-gel double diffusion assays. Single precipitation bands were detected for each antiserum when reacted against serum, but no bands were visible in reactions against the AM supernatants (antisera were used undiluted, and also in 1:10, 1:100, 1:1,000 dilutions). In addition, an attempt was made to neutralize neutrophil-activating capacity in the AM supernatants by immunologic means. No reduction of neutrophil-activating capacity was evident for any ofthe antisera-exposed specimens. Nor did antisera-exposed M 199 demonstrate alterations in neutrophil-activating properties as compared with M 199 alone.
Positive-pressure ultrafiltration and gel filtration. To determine the molecular weight of neutrophil-activating materials contained in AM culture supernatants, samples were first screened using a positive-pressure ultrafiltration apparatus. Ultrafiltration was carried out on two separate AM supernatant specimens. Exposure of neutrophils to UM-05 filter fractions resulted in 60 (specimen 1) and 74 (specimen 2) % fewer viable Pseudomonas after 120-min incubations, as compared with buffer controls. The UM-10 filter fractions contained no neutrophil-activating material, suggesting that the molecule(s) was between 500 and 10,000 D.
Based upon these screening studies, a Sephadex G-50 column was selected for more precise identification of molecular weight(s). Molecular sieve chromatography was carried out on five separate AM supernatant specimens (four 24-h cultures, one 4-h culture), and the results obtained were virtually identical. A representative experiment is shown in Fig. 3 . The major peak of neutrophil-activating material eluted with particles of -6,000 D; this material is referred to as "neutrophil-activating factor." A smaller peak of neutrophil-activating material was also detected, eluting with particles of -12,000 D.
Since previous studies have described low molecular weight AM-derived chemotactic factors (2, 3) and since certain chemotactic factors are known to stimulate nonlocomotive neutrophil activities (23, 25) , we considered the possibility that NAF and AM-derived chemotactic factors were related. The eluant fractions collected from three separate gel filtration experiments were thus assayed for chemotactic activity. Two peaks of chemotactic activity were consistently detected, and one such experiment is depicted in Fig. 4 weight chemotactic factor might possess weak neutrophilactivating capacity (Figs. 3 and 4) . Chromatofocusing. Three separate samples containing NAF, each of which had been partially purified by gel filtration, were subjected to chromatofocusing, which separates proteins according to their isoelectric points. Virtually identical results were obtained, and a representative chromatogram is shown in Fig. 5 . A single peak of neutrophil-activating material was consistently observed between pH 7.4 and 7.8 for all specimens. There was no NAF detectable in pooled fractions obtained from columns during regenerations with 1 M NaCl, indicating that all the neutrophil-activating material had been eluted 8 Thus, NAF appeared to be devoid of chemotactic activity after this second separation procedure. Enzyme digestion. NAF specimens prepared sequentially by Sephadex G-50 gel filtration and chromatofocusing were treated with trypsin, chymotrypsin, or neuraminidase in each of two experiments, yielding very similar results. A representative experiment is shown in Fig. 6 . All three enzymes produced between 50 to 70% reduction in NAF activity. The efficacy of digestion appeared to be time-dependent, particularly for chymotrypsin and neuraminidase.
Effect ofheat. Two separate samples containing NAF, each of which had been partially purified by gel filtration, were heated (560C) for 30 min. Heated and (paired) unheated specimens were then assayed for neutrophil-activating capacity, and results expressed as percent fewer viable Pseudomonas in reaction mixtures after 120-min incubations with neutrophils preexposed to the NAF-containing samples, as compared with neutrophils exposed to buffer only. These values were 72 and 62% for the unheated samples, and 69 and 60% for the respective heated samples, indicating that NAF is relatively heat-stable.
Influence of NAF on superoxide production by resting and stimulated neutrophils. The influence of NAF on O2 production by resting and stimulated neutrophils was evaluated. Eluant fractions obtained by Sephadex G-50 chromatography, and previously shown to contain NAF (see Fig. 3 ), were used for these experiments. Preexposure of neutrophils for 15 min to eluant fractions containing NAF did not result in increased production of°2 during the preexposure, or over subsequent 45-min periods, as compared with neutrophils preexposed to buffer alone (Fig. 7) We have addressed the possibility that NAF is one of the previously described AM secretory products that affects neutrophils, such as the high molecular weight (-10,000 D) (2) and the low molecular weight (-500 D) (2, 3) chemotactic factor, 5S, 12R-dihydroxy-6, 14-cis-8, 10-trans-eicosateraenoic acid (LTB4), a 5-lipoxygenase pathway metabolite ofarachidonic acid (6, 14, 21) , or complement fragments (4 (35) , the possibility that NAF is related to IL-I is remote. Only small amounts of IL-I are secreted by healthy human AM (36) . Furthermore, human IL-1 is -15,000 D, and has isoelectric points that are lower than those of NAF (37) .
Since an increase in neutrophil oxidative microbicidal activity may be one mechanism of action for NAF, experiments were carried out to examine the quantitative relationship of NAF to neutrophil respiratory burst. These studies demonstrated that NAF-mediated enhancement of O2 production by neutrophils was a graded response, only observed when submaximal stimuli were used. NAF did not increase the total°2 produced by a maximally stimulated neutrophil population. It was also of interest that NAF exposure alone did not directly stimulate a respiratory burst by neutrophils. This suggests that in the noninfected lung, it is unlikely that AM generation of NAF results in the production by neutrophils of oxygen radicals potentially toxic to lung tissues. While the mechanism by which NAF enhanced the neutrophil oxidase enzyme system responsible for°2 generation was not apparent, it is noteworthy that other polypeptides have been implicated in a dose-dependent stimulation of neutrophil respiratory burst (23, 38) . It is also possible that NAF influenced nonrespiratory mechanisms of neutrophil killing.
In summary, this study describes yet another facet of the already complex pulmonary host defense apparatus. Determination of the biologic significance of NAF will ultimately require an in vivo evaluation. However, this AM secretory product is clearly one with potential to directly enhance pulmonary host defenses against bacterial infection.
